Download TOLL Marbella Spain 2015

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
NLRP3 aggravates survival but not cardiac remodeling after myocardial infarction in mice
Mieke Louwe1,2,3, Ole Jørgen Kaasbøl3,4, Katrine Alfsnes1,2,3, Azita Rashidi1,2, Elisabeth Schrumpf1,2,
Solveig Bjærum Haugstad3,5,, Espen Melum1,2, Håvard Attramadal3,4, Ivar Sjaastad3,5, Pål Aukrust1,2,
Arne Yndestad1,2,3
1Research
Institute of Internal Medicine, Oslo University Hospital 2K.G. Jebsen Inflammation
Research Centre, University of Oslo, 3Centre for Heart Failure Research, University of Oslo, 4Institute
of Surgical Research, Oslo University Hospital, 5Institute of Experimental Medical Research, Oslo
University Hospital
Objectives: Myocardial infarction (MI) causes a sterile inflammatory response through activation
of the innate immune system. Upon activation of NLRP3, inflammasomes are formed together
with scaffold protein ASC and caspase-1, leading to maturation of the IL-1 family cytokines.
While the inflammatory response is a prerequisite for healing of the infarction, a dysregulated
response may have adverse effects promoting cardiac remodeling. We aimed to test whether
absence of NLRP3 affects post-MI remodeling.
Methods and Results: We first subjected C57Bl/6J (WT) and NLRP3 knock-out (NLRP3 KO)
mice to an MI by coronary artery ligation. WT mice had a high mortality rate (43%) primarily due to
ventricular rupture at day 4-6. The mortality rate was markedly reduced in NLRP3 KO mice (17%,
P<0.05), despite comparable infarct sizes and heart function 1 day post-MI. Notably, careful
evaluation of cardiac dimensions by MRI and histology did not reveal any differences in cardiac
remodeling up to 21 days post-MI. However, preliminary data indicates that a lack of NLRP3
leads to modulation of the activity of matrix metalloproteinases in the infarcted area . These
observations point at a primary role of NLRP3 in infarction healing. To investigate this more
closely, male WT or NLRP3 KO bone marrow chimeras were created and an MI was induced.
Transplantation of NLRP3 KO bone marrow into WT mice greatly improved p ost-MI survival
compared to WT to WT controls (100% vs. 53% survival, P<0.001).
Conclusions: NLRP3 activation in hematopoietic cells infiltrating in the myocardium disturbs
infarction healing, thereby causing ventricular rupture and acute heart failure. Ongoing studies
aim at defining which specific cell type is mediating this effect.